LI Nan,ZHANG Yi-yu,XIE Shuang-feng,et al.The Role of EO% and CRP in Risk Factors Analysis of Young Patients with Transfusion Related Adverse Reactions[J].Journal of Sun Yat-sen University(Medical Sciences),2023,44(02):335-341.
LI Nan,ZHANG Yi-yu,XIE Shuang-feng,et al.The Role of EO% and CRP in Risk Factors Analysis of Young Patients with Transfusion Related Adverse Reactions[J].Journal of Sun Yat-sen University(Medical Sciences),2023,44(02):335-341. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2023.0219.
The Role of EO% and CRP in Risk Factors Analysis of Young Patients with Transfusion Related Adverse Reactions
To discuss the correlation between young patients’ adverse transfusion reaction and pre-transfusion C reactive protein (CRP) level and EO% (percentage of eosinophils) .
Methods
2
The observation group was chosen from among sixty-six young patients who experienced transfusion-related adverse events between January 2019 and December 2020. For each patient chosen to be included in the observation group, another patient from the same department, with the same disease and gender, who had been hospitalized in the same month and received the same type of blood product transfusion, but had not experienced any transfusion-related adverse effects, was chosen to be in the control group. We examined and compared their ages, transfusion experiences, allergy backgrounds, EO%, and CRP levels in peripheral blood prior to transfusion. A receiver operating characteristic (ROC) curve was used to examine the diagnostic value of EO% and CRP for transfusion-related adverse events. Simultaneously, a logistic analysis was performed on the risk factors for transfusion-related adverse events.
Results
2
Pre-transfusion CRP was higher in patients with FNHTR in the observation group than it was in patients in the control group; pre-transfusion CRP was also higher in patients with ATR in the observation group than it was in patients in the control group. There were also statistically significant differences between these variables in the percentage of patients with transfusion history and pre-transfusion EO% (
P
<0.05). For the transfusion of different blood types, there was statistical significance in the occurrence of ATR and FNHTR (
P
<0.05). For the diagnosis of FNHTR, the CRP area under the ROC curve was 0.889, and the best cut-off value was 18.05 mg/L. For the diagnosis of ATR, the area under the ROC curve was 0.749, and the best cut-off values were 17.60 mg/L.
Conclusion
2
Pre-transfusion C-reactive protein level is an independent risk factor for FNHTR and ATR in young patients; the predictive value of EO% for adverse blood transfusion reactions is insufficient.
Zhang L , Yang J , Jiang WT . Research progress on strategies of reducing perioperative blood transfusion in liver transplantation [J]. Organ Transplanta , 2021 , 12 ( 1 ): 115 - 119 .
Delaney M , Wendel S , Bercovitz RS , et al . Transfusion reactions: prevention, diagnosis, and treatment [J]. Lancet , 2016 , 388 ( 10061 ): 2825 - 2836 .
Sanders RP , Maddirala SD , Geiger TL , et al . Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children [J]. Br J Haematol , 2005 , 130 ( 5 ): 781 - 787 .
Harvey AR , Basavaraju SV , Chung KW , et al . Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012 [J]. Transfusion , 2015 , 55 ( 4 ): 709 - 718 .
Kapur R , Kim M , Shanmugabhavananthan S , et al . C-reactive protein enhances murine antibody-mediated transfusion-related acute lung injury [J]. Blood , 2015 , 126 ( 25 ): 2747 - 2751 .
Li Y , Lin P , Chen MH . Association between C-reactive protein and adverse transfusion reactions in thalassemia [J]. Chin Health Stand Manage , 2022 , 13 ( 9 ): 151 - 154 .
Li S , Zhang XH . Role of Eotaxin and CRP in risk factor analysis of elderly patients with adverse reactions after blood transfusion [J]. Chin J Blood Trans , 2019 , 32 ( 07 ): 657 - 660 .
Jeffrey LC , Gordon G , Nancy MH , et al . Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage [J]. JAMA , 2016 , 316 ( 19 ): 2025 - 2035 .
Huang AQ , Sun K , Chen HH , et al . Incidence of adverse transfusion reactions and related influencing factors [J]. J Pract Med , 2020 , 36 ( 12 ): 1665 - 1668 .
Chen WY , Wang MQ , Gao JJ . A retrospective analysis of 398 cases of adverse reactions of blood transfusion in a tertiary hospital in a city [J]. Chin Fore Med Treat , 2022 , 41 ( 10 ): 49 - 53 .
Xie JR , Chen J , Luo Y , et al . Evaluation of the effect of leukocyte blood components on reducing adverse reactions of blood transfusion [J]. Chin J Blood Trans , 2017 , 30 ( 2 ): 192 - 194 .
Kang ZY , Liu C , Liu W , et al . Effect of pre-transfusion prophylactic medication on the incidence of adverse transfusion reactions [J]. Chin J Blood Trans , 2022 , 35 ( 6 ): 622 - 628 .